Opioid dependence continues to challenge millions worldwide, with traditional treatments like methadone and buprenorphine providing essential support but often requiring long-term commitment and carrying risks of prolonged dependence or incomplete recovery for some individuals. In 2026, growing interest surrounds medically supervised ibogaine treatment as a potential alternative or complementary approach for those struggling with opioid […]